Lynne Murray

Lynne Murray is an experienced professional in the biotechnology and pharmaceutical sectors, currently serving as a Venture Partner at SR One Capital Management and as Chief Scientific Officer at MiroBio Ltd. Previous roles include Vice President and Head of UK Research at Gilead Sciences, and leadership positions at AstraZeneca and MedImmune, where responsibilities spanned across research and development, strategy, and biology. Lynne holds an MBA from the University of Cambridge, a Postdoctoral fellowship from UCLA, a PhD in Immunology and Pathology from Imperial College London, and a BSc in Pharmacology from King's College London.